![Roy F. J. Davis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roy F. J. Davis
Technik-/Wissenschafts-/F&E-Leiter bei Immunexpress, Inc.
Profil
Roy F.
J.
Davis is currently the Chief Medical Officer at Immunexpress, Inc. He obtained a doctorate degree from the Medical College of Virginia.
Aktive Positionen von Roy F. J. Davis
Unternehmen | Position | Beginn |
---|---|---|
Immunexpress, Inc.
![]() Immunexpress, Inc. Miscellaneous Commercial ServicesCommercial Services Immunexpress, Inc. engages in development of revolutionary molecular diagnostics. The firm's SeptiCyte technology quantifies specific and multiple molecular markers from the patient?s own immune system for earlier detection and severity assessment of sepsis, as well as the better timing of drugs and other therapies. The company was founded by Richard Bruce Brandon, Roslyn Brandon and Mervyn Rees Thomas in and is headquartered in | Technik-/Wissenschafts-/F&E-Leiter | 22.10.2015 |
Ausbildung von Roy F. J. Davis
Medical College of Virginia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Immunexpress, Inc.
![]() Immunexpress, Inc. Miscellaneous Commercial ServicesCommercial Services Immunexpress, Inc. engages in development of revolutionary molecular diagnostics. The firm's SeptiCyte technology quantifies specific and multiple molecular markers from the patient?s own immune system for earlier detection and severity assessment of sepsis, as well as the better timing of drugs and other therapies. The company was founded by Richard Bruce Brandon, Roslyn Brandon and Mervyn Rees Thomas in and is headquartered in | Commercial Services |